Evidence map›Paper›PMID 42237418›Full record

ArticleBMC sports science, medicine & rehabilitation2026

TENS versus foam rolling for recovery after eccentric exercise-induced muscle damage in elite female volleyball players: an exploratory randomized controlled trial.

Shahla Shahnavazi, Mohammadreza Rezaeipour, Ahmad Mir

Registry-linked trialAbstract read
In one paragraph

Article in BMC sports science, medicine & rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07438197 (TENS Versus Foam Rolling for Recovery After Eccentric Exercise-Induced Muscle Damage in Elite Female Volleyball Players), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07438197 nacompletednot on this map

TENS Versus Foam Rolling for Recovery After Eccentric Exercise-Induced Muscle Damage in Elite Female Volleyball Players: A Comparative Study

TypeinterventionalSponsorUniversity of Sistan and BaluchestanRan2020 to 2020Enrolled30ConditionsDelayed-Onset Muscle Soreness (DOMS), Exercise-induced Muscle Damage, Muscle Recovery, Athletic InjuriesArmsTranscutaneous Electrical Nerve Stimulation (TENS), Foam Rolling (FR)
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shahla ShahnavaziDepartment of Sport Sciences, University of Sistan and Baluchestan, Zahedan, Iran.
Mohammadreza RezaeipourDepartment of Sport Sciences, University of Sistan and Baluchestan, Zahedan, Iran. rezaeipour@ped.usb.ac.ir.ORCID http://orcid.org/0000-0002-7848-4442
Ahmad MirGeneral Directorate of Sports and Youth of Sistan and Baluchestan Province, Zahedan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelayed-onset muscle soreness (DOMS) compromises performance and prolongs recovery in elite athletes. Transcutaneous electrical nerve stimulation (TENS) and foam rolling (FR) are widely used but have never been directly compared in elite female volleyball players. This study compared the effects of these two supplements on biochemical and functional recovery following eccentric exercise-induced muscle damage in elite female volleyball players.

methodsAs part of this exploratory pilot study, thirty elite female volleyball players (age 23.4 ± 2.8 years; height 178.6 ± 5.4 cm; body mass 68.2 ± 6.1 kg; training experience 8.3 ± 2.1 years in Iran's Premier League) were randomly assigned 1:1:1 to TENS (n = 10), FR (n = 10), or control (CON; n = 10) groups using concealed computer-generated allocation. DOMS was induced by five sets of 15 eccentric leg-press repetitions at 110% concentric one repetition maximum. TENS (120-150 Hz, 100 µs, 10-30 mA, 20 min) was applied to the dominant quadriceps and hamstrings. FR (20 min) targeted the quadriceps, hamstrings, iliotibial band, gastrocnemius, and gluteals muscles. Serum creatine kinase (CK), vertical jump height, and anaerobic peak power (Running based Anaerobic Sprint Test) were measured at baseline and 1, 24, and 48 h postexercise. Mixed-design repeated-measures ANOVA with Bonferroni-adjusted pairwise comparisons was used.

resultsCK showed a significant Group × Time interaction (p < 0.001, η²p = 0.24). TENS lowered CK vs. CON at 1 h (- 186 U/L, 95% CI - 289 to - 83; p = 0.001, d = 1.98), 24 h (- 312 U/L, 95% CI - 442 to - 182; p = 0.001, d = 2.32), and 48 h. FR lowered CK vs. CON only at 48 h (- 166 U/L, 95% CI - 273 to - 59; p = 0.003, d = 1.32). Vertical jump recovery at 48 h was superior in both interventions vs. CON (TENS + 4.8 cm, 95% CI 2.1-7.5, p = 0.001, d = 1.11; FR + 3.7 cm, 95% CI 1.4-6.4, p = 0.001, d = 0.85), reaching 96.3% and 95.7% of baseline vs. 85.8% in CON. No group differences were observed for anaerobic power (Group × Time p = 0.086, η²p = 0.08). Muscle soreness was lower in both active groups than in the CON group at 48 h (p < 0.01, d ≥ 1.48).

conclusionsIn this pilot cohort, TENS and FR improved recovery relative to control with different CK temporal patterns but comparable vertical jump restoration at 48 h. However, given the exploratory nature of the study, these results should be interpreted as preliminary. TENS had earlier CK reductions, relevant for 24-h recovery windows; however, both produced comparable functional recovery by 48 h, and neither showed consistent superiority across outcomes. FR offers a practical, cost-effective alternative to achieve equivalent functional restoration within 48 h.

trial registrationClinicalTrials.gov, NCT07438197, registered on 22/02/2026. Retrospectively registered.

Indexed as

Creatine kinaseDelayed-onset muscle sorenessEccentric exerciseElite athletesFoam rollingMuscle damage recoveryNeuromuscular performanceSelf-myofascial releaseTranscutaneous electrical nerve stimulationVolleyball

Identifiers

PMID42237418
PMCPMC13326353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.